Join
Live feed
·
INSIDERFilingvia Quantisnow
Rein Therapeutics Inc. logo

Director Von Rickenbach Josef H bought $49,561 worth of Common stock (47,060 units at $1.05), increasing direct ownership by 305% to 62,514 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
RNTX· Rein Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track RNTX (Rein Therapeutics Inc.) and more on Quantisnow.